US Patent Issued to NEW FRONTIER LABS on April 21 for "Azelaic acid esters in the treatment or prevention of dyslipidemia and associated conditions" (Texas Inventors)

ALEXANDRIA, Va., April 21 -- United States Patent no. 12,605,354, issued on April 21, was assigned to NEW FRONTIER LABS LLC (San Antonio).

"Azelaic acid esters in the treatment or prevention of dyslipidemia and associated conditions" was invented by Robert T. Streeper (San Antonio) and Elzbieta Izbicka (San Antonio).

According to the abstract* released by the U.S. Patent & Trademark Office: "Pharmaceutical compositions comprising a C1-C4 alkyl ester azelate, such as diethyl azelate (DEA), dimethyl azelate (DMA), di-isopropyl azelate (DiPA), di-isobutyl azelate (DiBuA), and di-2-pentyl azelate (D2PA), and methods of, inter alia, improving abnormal lipid levels and treating or preventing dyslipidemias and/or diseases of conditions associate...